Yi Chen Hao Zhang Junfeng Shi Tongshan Wang
10.2147/OTT.S279004
Onco Targets Ther
2020 Dec 3;13:12471-12476.
pd-1 rccep camrelizumab immune checkpoint inhibitor pulmonary pleomorphic carcinoma reactive skin capillary endothelial cell proliferation
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33299330/
Case Reports
PMC7721275
33299330
A Partial Response of Pulmonary Pleomorphic Carcinoma to Camrelizumab (PD1 Monoclonal Antibody) Monotherapy: A Case Report
2020